Hassan J, Saeed S, Deka L, Jasim Uddin M, Das D
Pharmaceutics. 2024; 16(2).
PMID: 38399314
PMC: 10892549.
DOI: 10.3390/pharmaceutics16020260.
Balmain A
Eur J Epidemiol. 2022; 38(12):1251-1258.
PMID: 36512199
PMC: 10757908.
DOI: 10.1007/s10654-022-00933-x.
Wang Y, Boland C, Goel A, Wodarz D, Komarova N
Elife. 2022; 11.
PMID: 35416770
PMC: 9007589.
DOI: 10.7554/eLife.71953.
Belikov A, Vyatkin A, Leonov S
PeerJ. 2021; 9:e11976.
PMID: 34434669
PMC: 8351573.
DOI: 10.7717/peerj.11976.
Pires J, Silva G, Weyssow T, Conforte A, Pagnoncelli D, Silva F
Front Genet. 2021; 12:624259.
PMID: 33679888
PMC: 7935533.
DOI: 10.3389/fgene.2021.624259.
Resolving Peto's paradox: Modeling the potential effects of size-related metabolic changes, and of the evolution of immune policing and cancer suppression.
Nunney L
Evol Appl. 2020; 13(7):1581-1592.
PMID: 32821274
PMC: 7428811.
DOI: 10.1111/eva.12993.
Genetic Engineering of Zebrafish in Cancer Research.
Raby L, Volkel P, Le Bourhis X, Angrand P
Cancers (Basel). 2020; 12(8).
PMID: 32759814
PMC: 7464884.
DOI: 10.3390/cancers12082168.
Why do young people get cancer?.
Kentsis A
Pediatr Blood Cancer. 2020; 67(7):e28335.
PMID: 32391946
PMC: 7582786.
DOI: 10.1002/pbc.28335.
Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations.
Anandakrishnan R, Varghese R, Kinney N, Garner H
PLoS Comput Biol. 2019; 15(3):e1006881.
PMID: 30845172
PMC: 6424461.
DOI: 10.1371/journal.pcbi.1006881.
Alzheimer's disease as a multistage process: an analysis from a population-based cohort study.
Licher S, van der Willik K, Vinke E, Yilmaz P, Fani L, Schagen S
Aging (Albany NY). 2019; 11(4):1163-1176.
PMID: 30811346
PMC: 6402512.
DOI: 10.18632/aging.101816.
A Simple 3-Parameter Model for Cancer Incidences.
Zhang X, Frohlich H, Grigoriev D, Vakulenko S, Zimmermann J, Weber A
Sci Rep. 2018; 8(1):3388.
PMID: 29467476
PMC: 5821839.
DOI: 10.1038/s41598-018-21734-x.
The number of key carcinogenic events can be predicted from cancer incidence.
Belikov A
Sci Rep. 2017; 7(1):12170.
PMID: 28939880
PMC: 5610194.
DOI: 10.1038/s41598-017-12448-7.
Optical Control of Tumor Induction in the Zebrafish.
Feng Z, Nam S, Hamouri F, Aujard I, Ducos B, Vriz S
Sci Rep. 2017; 7(1):9195.
PMID: 28835665
PMC: 5569104.
DOI: 10.1038/s41598-017-09697-x.
Toward precision medicine of breast cancer.
Carels N, Spinasse L, Tilli T, Tuszynski J
Theor Biol Med Model. 2016; 13:7.
PMID: 26925829
PMC: 4772532.
DOI: 10.1186/s12976-016-0035-4.
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.
Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis C, Hardiman O
Lancet Neurol. 2014; 13(11):1108-1113.
PMID: 25300936
PMC: 4197338.
DOI: 10.1016/S1474-4422(14)70219-4.
Turning ecology and evolution against cancer.
Korolev K, Xavier J, Gore J
Nat Rev Cancer. 2014; 14(5):371-80.
PMID: 24739582
DOI: 10.1038/nrc3712.
What can be learnt about disease progression in breast cancer dormancy from relapse data?.
Willis L, Graham T, Alarcon T, Alison M, Tomlinson I, Page K
PLoS One. 2013; 8(5):e62320.
PMID: 23671591
PMC: 3646031.
DOI: 10.1371/journal.pone.0062320.
Somatic alterations contributing to metastasis of a castration-resistant prostate cancer.
Nickerson M, Im K, Misner K, Tan W, Lou H, Gold B
Hum Mutat. 2013; 34(9):1231-41.
PMID: 23636849
PMC: 3745530.
DOI: 10.1002/humu.22346.
Modelling the evolution of genetic instability during tumour progression.
Datta R, Gutteridge A, Swanton C, Maley C, Graham T
Evol Appl. 2013; 6(1):20-33.
PMID: 23396531
PMC: 3567468.
DOI: 10.1111/eva.12024.
The life history of 21 breast cancers.
Nik-Zainal S, Van Loo P, Wedge D, Alexandrov L, Greenman C, Lau K
Cell. 2012; 149(5):994-1007.
PMID: 22608083
PMC: 3428864.
DOI: 10.1016/j.cell.2012.04.023.